Zante Greg

EDGAR CIK 0001264949

Viking Therapeutics, Inc. - VKTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($2.27) M
-54,575 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/03/2025
07/03/2025
Sell
-4,266 @ $27.76
 ($118,428) 168,660 (-2.47%) Direct
01/06/2025
01/06/2025
Sell
-50,309 @ $42.75
 ($2,150,595) 165,259 (-23.34%) Direct